Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Zynerba Pharmaceuticals Inc (ZYNE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Zynerba Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.900 +0.030    +3.40%
15:09:03 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 248,285
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.860 - 0.950
Zynerba Pharma 0.900 +0.030 +3.40%

ZYNE Earnings

 
The latest earnings per stock, revenues and financial reports for Zynerba Pharmaceuticals Inc (ZYNE).
InvestingPro Earnings Insights
Latest Release

Aug 10, 2022

EPS / Forecast

-0.24 / -0.23

Revenue / Forecast

0.00 / 0.00

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Nov 14, 2022 09/2022 -- /  -0.23 -- /  0.00
Aug 10, 2022 06/2022 -0.24 /  -0.23 0.00 /  0.00
May 16, 2022 03/2022 -0.21 /  -0.228 0.00 /  0.00
Mar 01, 2022 12/2021 -0.22 /  -0.2633 0.00 /  0.00
Nov 15, 2021 09/2021 -0.26 /  -0.252 0.00 /  0.00
Aug 09, 2021 06/2021 -0.25 /  -0.2229 0.00 /  0.00
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ZYNE Comments

Write your thoughts about Zynerba Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ramba Łej
Kubizm Sep 20, 2022 7:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.zynerba.com/zynerba-pharmaceuticals-presents-positive-data-from-phase-2-inspire-trial-in-22q-at-the-society-for-the-study-of-behavioural-phenotypes-ssbp-24th-international-research-symposium/
Ramba Łej
Kubizm Aug 02, 2022 5:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.zynerba.com/zynerba-pharmaceuticals-enters-into-equity-purchase-agreement-for-up-to-20-million-with-lincoln-park-capital/ In case you missed it:)
Ramba Łej
Kubizm Jun 09, 2022 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wish i could affort buying more on this price...
Ramba Łej
Kubizm May 05, 2022 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in this market condition and inflation ZYNE is on its way to default b4 FX reconnect results:D Good Job:D
Павел Федоров
Павел Федоров May 05, 2022 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They are getting money from instututionals for the cash flow, dont think they wont get it again to survive till sales start
Ramba Łej
Kubizm May 05, 2022 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Did you spot that ZYNE is no longer calling itself in bio "leader" in treating rare/near-rare diseases?:D
Ramba Łej
Kubizm Mar 16, 2022 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
orphan drug registration is a bit fail for ZYNE - orphan drug registration is granted for drugs for diseases so rare that its economically senseless to conduct proper research and its known that production costs will not be covered with incomes. So for "leader" in treatment rare and near-rare diseases it's like a cofirmation that Zyne won't make money...
Ramba Łej
Kubizm Jan 07, 2022 1:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
below 2.7 its a freeway to 0.001 per share
Павел Федоров
Павел Федоров Jan 07, 2022 1:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I still think its a perfect bet, but it became more longterm cause of FDA pro-GW position
Ramba Łej
Kubizm Dec 17, 2021 6:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Right now ZYNE price tests still important support price lvl. 3.3$ had been tested 4 times and for the 5th time two days ago. Its important technically for one more reason, that going up from here could lead to breach of downtrend which last practically from the very begininng of ZYNE presence on NSDAQ. Goung up from here would make downtrend looks weaker with lower highs but also higher lows. Overall on the chart Zyne still needs much more trust from investors.
Ramba Łej
Kubizm Dec 17, 2021 6:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1639742320_57753.jpg
1639742320_57753.jpg Dunno how to paste charts from other sources so ...
Ramba Łej
Kubizm Dec 14, 2021 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Im suprised that Zyne is lagging so much alike cannabis market even with absolutely different profile and product. Disappointing tbh.
Ramba Łej
Kubizm Nov 12, 2021 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ah and only thing we wait for is that they spent less than consensus forsee, and imo it's practically out of the reach with whole market fluctuating especially basic materials. What you think?
Ramba Łej
Kubizm Oct 22, 2021 10:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you think Zyne will seek FDA approval for conditions other than f-x before Reconnect results?k is it possible Zyne files for FDA acceptantra
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email